CXCL5 and multiminicore myopathy: In contrast, in this study, we found no association between HLA-DRB1*04:10 and polymorphism in RNF213 and no difference in the soluble CD163 and CXCL5 serum concentrations in MMD patients between the RNF213 variant and normal variant groups [11].